These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20206138)

  • 1. Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin.
    Leonti M; Casu L; Raduner S; Cottiglia F; Floris C; Altmann KH; Gertsch J
    Biochem Pharmacol; 2010 Jun; 79(12):1815-26. PubMed ID: 20206138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
    Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD; Williamson EM
    J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity.
    Hadcock JR; Griffith DA; Iredale PA; Carpino PA; Dow RL; Black SC; O'Connor R; Gautreau D; Lizano JS; Ward K; Hargrove DM; Kelly-Sullivan D; Scott DO
    Biochem Biophys Res Commun; 2010 Apr; 394(2):366-71. PubMed ID: 20211605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.
    Muccioli GG; Wouters J; Charlier C; Scriba GK; Pizza T; Di Pace P; De Martino P; Poppitz W; Poupaert JH; Lambert DM
    J Med Chem; 2006 Feb; 49(3):872-82. PubMed ID: 16451053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.
    Merighi S; Simioni C; Gessi S; Varani K; Borea PA
    Biochem Pharmacol; 2010 Feb; 79(3):471-7. PubMed ID: 19766600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
    Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
    J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
    Albanesi C; Cavani A; Girolomoni G
    J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of palmitoylethanolamide in contact allergic dermatitis.
    Petrosino S; Cristino L; Karsak M; Gaffal E; Ueda N; Tüting T; Bisogno T; De Filippis D; D'Amico A; Saturnino C; Orlando P; Zimmer A; Iuvone T; Di Marzo V
    Allergy; 2010 Jun; 65(6):698-711. PubMed ID: 19909294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists.
    Lange JH; Kruse CG
    Drug Discov Today; 2005 May; 10(10):693-702. PubMed ID: 15896682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
    Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
    Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sterically hindered cannabinoid CB1 receptor ligands.
    Urbani P; Cascio MG; Ramunno A; Bisogno T; Saturnino C; Di Marzo V
    Bioorg Med Chem; 2008 Aug; 16(15):7510-5. PubMed ID: 18579386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted pyrimidines as cannabinoid CB1 receptor ligands.
    Kim MJ; Kim JY; Seo HJ; Lee J; Lee SH; Kim MS; Kang J; Kim J; Lee J
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4692-7. PubMed ID: 19596576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
    De Vry J; Denzer D; Reissmueller E; Eijckenboom M; Heil M; Meier H; Mauler F
    J Pharmacol Exp Ther; 2004 Aug; 310(2):620-32. PubMed ID: 15140913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
    Behrenswerth A; Volz N; Toräng J; Hinz S; Bräse S; Müller CE
    Bioorg Med Chem; 2009 Apr; 17(7):2842-51. PubMed ID: 19278853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells.
    Xiao JC; Jewell JP; Lin LS; Hagmann WK; Fong TM; Shen CP
    Brain Res; 2008 Oct; 1238():36-43. PubMed ID: 18761332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists.
    Lange JH; Coolen HK; van Stuivenberg HH; Dijksman JA; Herremans AH; Ronken E; Keizer HG; Tipker K; McCreary AC; Veerman W; Wals HC; Stork B; Verveer PC; den Hartog AP; de Jong NM; Adolfs TJ; Hoogendoorn J; Kruse CG
    J Med Chem; 2004 Jan; 47(3):627-43. PubMed ID: 14736243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and biological effects of CB1 cannabinoid receptor in rat parotid gland.
    Busch L; Sterin-Borda L; Borda E
    Biochem Pharmacol; 2004 Nov; 68(9):1767-74. PubMed ID: 15450942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic contact dermatitis from falcarinol isolated from Schefflera arboricola.
    Hansen L; Hammershøy O; Boll PM
    Contact Dermatitis; 1986 Feb; 14(2):91-3. PubMed ID: 2940058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation.
    Gaffal E; Cron M; Glodde N; Bald T; Kuner R; Zimmer A; Lutz B; Tüting T
    J Immunol; 2013 May; 190(10):4929-36. PubMed ID: 23585676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.